Source: PR NEWSWIRE

Press Release: Pulsar Vascular : Pulsar Vascular Announces Completion of Enrollment for U.S. Clinical Trial in the Treatment for Intracranial Aneurysms

SAN JOSE, Calif., Oct. 19, 2015 /PRNewswire/ -- Pulsar Vascular, an innovative medical device company, focused on breakthrough technology in the neurovascular space, announced today that they have reached the target enrollment in their clinical trial for PulseRider®, the company's...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Rob Abrams's photo - President & CEO of Pulsar Vascular

President & CEO

Rob Abrams

CEO Approval Rating

84/100

Read more